JP2007514638A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007514638A5 JP2007514638A5 JP2006516318A JP2006516318A JP2007514638A5 JP 2007514638 A5 JP2007514638 A5 JP 2007514638A5 JP 2006516318 A JP2006516318 A JP 2006516318A JP 2006516318 A JP2006516318 A JP 2006516318A JP 2007514638 A5 JP2007514638 A5 JP 2007514638A5
- Authority
- JP
- Japan
- Prior art keywords
- disorders
- mixture
- dmf
- water
- alcoholism
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000007848 Alcoholism Diseases 0.000 claims 1
- 208000008665 Gastrointestinal Disease Diseases 0.000 claims 1
- 206010021425 Immune system disease Diseases 0.000 claims 1
- 206010061284 Mental disease Diseases 0.000 claims 1
- 206010057852 Nicotine dependence Diseases 0.000 claims 1
- 201000007930 alcohol dependence Diseases 0.000 claims 1
- 235000014632 disordered eating Nutrition 0.000 claims 1
- 201000006180 eating disease Diseases 0.000 claims 1
- 230000002757 inflammatory Effects 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- 239000000203 mixture Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N acetic acid ethyl ester Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 2
- YMWUJEATGCHHMB-UHFFFAOYSA-N methylene dichloride Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- UCTNTYHJFWMUBD-UHFFFAOYSA-M 4-chloro-3-oxobutanoate Chemical compound [O-]C(=O)CC(=O)CCl UCTNTYHJFWMUBD-UHFFFAOYSA-M 0.000 description 1
- UKERFDAVNWMNJI-UHFFFAOYSA-N 6-(4-chlorophenyl)-5-(2,4-dichlorophenyl)-2-(methoxymethyl)pyridine-3-carboxylic acid Chemical compound C=1C=C(Cl)C=C(Cl)C=1C=1C=C(C(O)=O)C(COC)=NC=1C1=CC=C(Cl)C=C1 UKERFDAVNWMNJI-UHFFFAOYSA-N 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- CMKOJBYFNYDATH-UHFFFAOYSA-N ethyl 4-methoxy-3-oxobutanoate Chemical compound CCOC(=O)CC(=O)COC CMKOJBYFNYDATH-UHFFFAOYSA-N 0.000 description 1
- 235000019439 ethyl acetate Nutrition 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000004435 hydrogen atoms Chemical class [H]* 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
Description
製造例 3a
6−(4−クロロフェニル)−5−(2,4−ジクロロフェニル)−2−メトキシメチルピリジン−3−カルボン酸
この化合物は、次の手順に従って得ることもできる。
A） エチル 4−メトキシ−3−オキソブタノエート
水素化ナトリウム(14 g)を、窒素下に、DMF (200 ml)中に導入し、混合物を0℃に冷却し、DMF(100 ml)中のメタノール(6 ml)を滴下し、混合物を撹拌しながら、0℃で1時間、次いでATで1時間放置する。DMF(100 ml)中の4−クロロ−3−オキソブタノエート(17.32 g)を0℃で加え、混合物を撹拌しながら一夜放置する。反応媒体を0℃で水中に注ぎ、次いで混合物をDCMで抽出し、水で3回、次いでNaCl飽和溶液で3回洗浄する。水相を採取し、pH ＞ 4の酸性にし、次いでDCMで抽出し、水で3回洗浄し、次いでNaCl飽和溶液で洗浄する。生成物を乾燥し、次いで濃縮乾固する。生成物を、シクロヘキサン／EtOAc(80/20; v/v)で溶出するCelite（商標）クロマトグラフィにかけて、所期の化合物(3.90 g)を液体の形態で得る。
6−(4−クロロフェニル)−5−(2,4−ジクロロフェニル)−2−メトキシメチルピリジン−3−カルボン酸
この化合物は、次の手順に従って得ることもできる。
A） エチル 4−メトキシ−3−オキソブタノエート
水素化ナトリウム(14 g)を、窒素下に、DMF (200 ml)中に導入し、混合物を0℃に冷却し、DMF(100 ml)中のメタノール(6 ml)を滴下し、混合物を撹拌しながら、0℃で1時間、次いでATで1時間放置する。DMF(100 ml)中の4−クロロ−3−オキソブタノエート(17.32 g)を0℃で加え、混合物を撹拌しながら一夜放置する。反応媒体を0℃で水中に注ぎ、次いで混合物をDCMで抽出し、水で3回、次いでNaCl飽和溶液で3回洗浄する。水相を採取し、pH ＞ 4の酸性にし、次いでDCMで抽出し、水で3回洗浄し、次いでNaCl飽和溶液で洗浄する。生成物を乾燥し、次いで濃縮乾固する。生成物を、シクロヘキサン／EtOAc(80/20; v/v)で溶出するCelite（商標）クロマトグラフィにかけて、所期の化合物(3.90 g)を液体の形態で得る。
Claims (1)
- 摂食障害、胃腸障害、炎症性症状、免疫系疾患、精神異常、アルコール中毒またはニコチン中毒の治療のための、請求項７に記載の医薬組成物。
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0307757A FR2856684B1 (fr) | 2003-06-26 | 2003-06-26 | Derives de diphenylpyridine, leur preparation et leur application en therapeutique |
| PCT/FR2004/001581 WO2005000817A2 (fr) | 2003-06-26 | 2004-06-24 | Derives de diphenylpyridine, leur preparation et leur application en therapeutique |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007514638A JP2007514638A (ja) | 2007-06-07 |
| JP2007514638A5 true JP2007514638A5 (ja) | 2007-08-30 |
| JP4669839B2 JP4669839B2 (ja) | 2011-04-13 |
Family
ID=33515448
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006516318A Expired - Fee Related JP4669839B2 (ja) | 2003-06-26 | 2004-06-24 | ジフェニルピリジン誘導体、その製造法および治療用途 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US7345059B2 (ja) |
| EP (1) | EP1641758B1 (ja) |
| JP (1) | JP4669839B2 (ja) |
| KR (1) | KR20060025191A (ja) |
| CN (1) | CN1832945A (ja) |
| AR (1) | AR044906A1 (ja) |
| AT (1) | ATE412635T1 (ja) |
| AU (1) | AU2004251914B9 (ja) |
| BR (1) | BRPI0411762A (ja) |
| CA (1) | CA2528619A1 (ja) |
| DE (1) | DE602004017463D1 (ja) |
| FR (1) | FR2856684B1 (ja) |
| IL (1) | IL172733A0 (ja) |
| MX (1) | MXPA05014222A (ja) |
| TW (1) | TW200504019A (ja) |
| WO (1) | WO2005000817A2 (ja) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2479744A1 (en) | 2002-03-28 | 2003-10-09 | Paul E. Finke | Substituted 2,3-diphenyl pyridines |
| EP1546115A4 (en) | 2002-09-27 | 2010-08-04 | Merck Sharp & Dohme | SUBSTITUTED PYRIMIDINES |
| CA2602787C (en) | 2005-04-06 | 2013-12-24 | F. Hoffmann-La Roche Ag | Pyridine-3-carboxamide derivatives as cb1 inverse agonists |
| GB0514739D0 (en) * | 2005-07-19 | 2005-08-24 | Astrazeneca Ab | Therapeutic agents |
| WO2007039797A1 (en) * | 2005-10-03 | 2007-04-12 | Pfizer Products Inc. | Use of cannabinoid receptor-1 antagonist for treating inflammation and arthritis |
| FR2899899A1 (fr) * | 2006-04-14 | 2007-10-19 | Sanofi Aventis Sa | Derives d'aminomethyl pyridine, leur preparation et leur application en therapeutique |
| US7629346B2 (en) | 2006-06-19 | 2009-12-08 | Hoffmann-La Roche Inc. | Pyrazinecarboxamide derivatives as CB1 antagonists |
| FR2904827B1 (fr) * | 2006-08-11 | 2008-09-19 | Sanofi Aventis Sa | Derives de 5,6-bisaryl-2-pyridine-carboxamide, leur preparation et leur application en therapeutique comme antiganistes des recepteurs a l'urotensine ii |
| US7781593B2 (en) | 2006-09-14 | 2010-08-24 | Hoffmann-La Roche Inc. | 5-phenyl-nicotinamide derivatives |
| FR2927330B1 (fr) * | 2008-02-07 | 2010-02-19 | Sanofi Aventis | Derives de 5,6-bisaryl-2-pyridine-carboxamide, leur preparation et leur application en therapeutique comme antagonistes des recepteurs a l'urotensine ii |
| US8410107B2 (en) | 2010-10-15 | 2013-04-02 | Hoffmann-La Roche Inc. | N-pyridin-3-yl or N-pyrazin-2-yl carboxamides |
| US8669254B2 (en) | 2010-12-15 | 2014-03-11 | Hoffman-La Roche Inc. | Pyridine, pyridazine, pyrimidine or pyrazine carboxamides as HDL-cholesterol raising agents |
| CN102276517B (zh) * | 2011-06-29 | 2012-11-28 | 孙光辉 | 二芳基吡啶类药物的合成方法 |
| EP2903978B1 (en) * | 2012-10-05 | 2022-12-07 | Rigel Pharmaceuticals, Inc. | Gdf-8 inhibitors |
| EP3456716A4 (en) * | 2016-05-09 | 2019-11-06 | Nippon Soda Co., Ltd. | CYCLIC AMINE COMPOUND AND PEST CONTROL AGENT |
| JP6916279B2 (ja) | 2016-07-12 | 2021-08-11 | レヴォリューション・メディスンズ，インコーポレイテッド | アロステリックｓｈｐ２阻害剤としての２，５−二置換３−メチルピラジンおよび２，５，６−三置換３−メチルピラジン |
| JP7240320B2 (ja) * | 2017-01-23 | 2023-03-15 | レヴォリューション・メディスンズ，インコーポレイテッド | アロステリックｓｈｐ２阻害剤としてのピリジン化合物 |
| SG11201906209SA (en) | 2017-01-23 | 2019-08-27 | Revolution Medicines Inc | Bicyclic compounds as allosteric shp2 inhibitors |
| EP3678703A1 (en) | 2017-09-07 | 2020-07-15 | Revolution Medicines, Inc. | Shp2 inhibitor compositions and methods for treating cancer |
| TW201930292A (zh) | 2017-10-12 | 2019-08-01 | 美商銳新醫藥公司 | 作為變構ｓｈｐ２抑制劑的吡啶、吡嗪和三嗪化合物 |
| WO2019118909A1 (en) | 2017-12-15 | 2019-06-20 | Revolution Medicines, Inc. | Polycyclic compounds as allosteric shp2 inhibitors |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2198737B1 (ja) * | 1972-09-13 | 1975-11-28 | Serdex | |
| FR2248027B2 (ja) * | 1973-10-18 | 1977-09-09 | Serdex | |
| FR2612189B1 (fr) * | 1987-03-13 | 1989-06-23 | Roussel Uclaf | Nouveaux derives de la pyridine, leur procede de preparation et les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions les renfermant |
| GB9210436D0 (en) * | 1992-05-15 | 1992-07-01 | Neave Andrew J | A light projector for use in conjunction with light guides |
| FR2741621B1 (fr) * | 1995-11-23 | 1998-02-13 | Sanofi Sa | Nouveaux derives de pyrazole, procede pour leur preparation et compositions pharmaceutiques en contenant |
| FR2816938B1 (fr) * | 2000-11-22 | 2003-01-03 | Sanofi Synthelabo | Derives de 3-aroylindole, leur procede de preparation et les compositions pharmaceutiques en contenant |
| CA2479744A1 (en) * | 2002-03-28 | 2003-10-09 | Paul E. Finke | Substituted 2,3-diphenyl pyridines |
| FR2838439B1 (fr) * | 2002-04-11 | 2005-05-20 | Sanofi Synthelabo | Derives de terphenyle, leur preparation, les compositions pharmaceutqiues en contenant |
| FR2838438A1 (fr) * | 2002-04-11 | 2003-10-17 | Sanofi Synthelabo | Derives de diphenylpyridine,leur preparation, les compositions pharmaceutiques en contenant |
-
2003
- 2003-06-26 FR FR0307757A patent/FR2856684B1/fr not_active Expired - Fee Related
-
2004
- 2004-06-24 DE DE602004017463T patent/DE602004017463D1/de not_active Expired - Lifetime
- 2004-06-24 KR KR1020057024811A patent/KR20060025191A/ko not_active Application Discontinuation
- 2004-06-24 BR BRPI0411762-0A patent/BRPI0411762A/pt not_active IP Right Cessation
- 2004-06-24 CA CA002528619A patent/CA2528619A1/fr not_active Abandoned
- 2004-06-24 AU AU2004251914A patent/AU2004251914B9/en not_active Ceased
- 2004-06-24 CN CNA2004800224859A patent/CN1832945A/zh active Pending
- 2004-06-24 EP EP04767437A patent/EP1641758B1/fr not_active Expired - Lifetime
- 2004-06-24 WO PCT/FR2004/001581 patent/WO2005000817A2/fr active Application Filing
- 2004-06-24 TW TW093118318A patent/TW200504019A/zh unknown
- 2004-06-24 AT AT04767437T patent/ATE412635T1/de not_active IP Right Cessation
- 2004-06-24 MX MXPA05014222A patent/MXPA05014222A/es active IP Right Grant
- 2004-06-24 JP JP2006516318A patent/JP4669839B2/ja not_active Expired - Fee Related
- 2004-06-25 AR ARP040102227A patent/AR044906A1/es unknown
-
2005
- 2005-12-21 IL IL172733A patent/IL172733A0/en unknown
- 2005-12-22 US US11/316,510 patent/US7345059B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007514638A5 (ja) | ||
| RU2764243C2 (ru) | Гетероциклические соединения в качестве ингибиторов PAD | |
| ES2244064T3 (es) | Nuevos mimeticos de guanidina como inhibidores del factor xa. | |
| TWI332500B (en) | Novel compounds | |
| CN103492372B (zh) | 调节雄激素受体的甲酰胺类化合物 | |
| JP3325263B2 (ja) | Ｃｏｘ−２のインヒビターとして有用なジアリールピリジンの製造方法 | |
| CN111433196B (zh) | 缓激肽b2受体拮抗剂及其用途 | |
| JP2014518886A (ja) | 関節炎の治療に有用な新規イミダゾール誘導体 | |
| JP2008526692A5 (ja) | ||
| JP2007531756A5 (ja) | ||
| JPH09503214A (ja) | 抗炎症活性及び／又は鎮痛活性を有する硝酸エステル類及びそれらの製造方法 | |
| JP2007534638A5 (ja) | ||
| CN105473573B (zh) | 用作激酶抑制剂的咔唑甲酰胺化合物 | |
| CN109071491A (zh) | 吲唑的合成 | |
| JPH05507931A (ja) | Ｈｉｖ―阻害性ベンゼンアセトアミド誘導体 | |
| FR2891825A1 (fr) | Derives de la 1-amino-isoquinoline, leur preparation et leur application en therapeutique | |
| JP2006509781A5 (ja) | ||
| JP2002529463A (ja) | 化合物 | |
| TW201035050A (en) | Bis aromatic compounds for use as LTC4 synthase inhibitors | |
| CZ293246B6 (cs) | Způsob výroby 2-aryl-3-aryl-5-halogenpyridinů | |
| JP2002510333A (ja) | １，５−ジフェニルピラゾール誘導体 | |
| KR20130119927A (ko) | 이미다졸 유도체, 그의 제조 방법 및 용도 | |
| JP2006169138A (ja) | ピラゾロピリジンピラゾロン誘導体とその付加塩及びｐｄｅ阻害剤 | |
| CN114621218A (zh) | 一种唑吡坦中间体化合物 | |
| CN103864691A (zh) | 化合物abt-869的制备方法 |